Opko Health PE ratio OPK

Share price divided by earnings per share over the last twelve months, since 2016.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 29.1×; Feb 2022
10-year median: 34.3×
10-year range: 18.4× to 97.0×
Peer median: 14.1×

Opko Health has no meaningful PE ratio today: it lost $0.09 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2022, at 29.1×.

On the days it had one over the last ten years, its median was 34.3×, from 18.4× in Jul 2021 to 97.0× in Mar 2021.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2022	29.1×	26.8×	41.2×
2021	43.7×	18.4×	97.0×
2020	n/m a value too high to mean anything
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	n/m a value too high to mean anything
2016	39.1×	36.5×	74.4×

Against its peers

Companies in Drug Manufacturers - General nearest Opko Health's size, closest first, today.

Company	PE ratio
OPKOpko Health	n/m
OMEROmeros	10.9×
AMPHAmphastar Pharmaceuticals	14.8×
PCRXPacira BioSciences	104×
ANABAnaptysbio	10.7×
PAHCPhibro Animal Health	15.9×
ANIPANI Pharmaceuticals	15.4×
ABUSArbutus Biopharma	5.4×
COLLCollegium Pharmaceutical	18.5×
HRMYHarmony Biosciences	11.7×
PBHPrestige Consumer Healthcare	13.4×
Peer median	14.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Opko Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.